CLINICAL_TRIALS
trial_result
· 2014-12-12
Clinical Trial Update: The Tolerability and Effect of Food on the Pharmacokinetics of a Single 800 mg Oral Dose of BIA 2-093 [Phase 1]
Summary
This Phase 1 trial evaluated tolerability and how food affects the pharmacokinetics of a single 800 mg oral dose of BIA 2-093 in epilepsy.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bial - Portela C S.A. | Conditions: Epilepsy | Phase 1 | Status: COMPLETED | Results posted: 2014-12-12